Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Multiple effects of Escherichia coli Nissle 1917 on growth, biofilm formation, and inflammation cytokines profile of Clostridium perfringens type A strain CP4. ✅
Go to Publication ✅
Pathogens and disease (Pathog Dis ) Vol: 70 Issue 3 Pages: 390-400 Pub: 2014 Apr Epub: 2014 Mar 11 Authors Jiang Y , Kong Q , Roland KL , Wolf A , Curtiss R 3rd , |
|
|
Multiple effects of Escherichia coli Nissle 1917 on growth, biofilm formation, and inflammation cytokines profile of Clostridium perfringens type A strain CP4. ✅
Go to Publication ✅
Pathogens and disease (Pathog Dis ) Vol: 70 Issue 3 Pages: 390-400 Pub: 2014 Apr Epub: 2014 Mar 11 Authors Jiang Y , Kong Q , Roland KL , Wolf A , Curtiss R 3rd , |
|
|
Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles modulate the intestinal microbiome and host gut-liver metabolome in obese and diabetic mice. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 14 Issue Pages: 1219763 Pub: 2023 Epub: 2023 Aug 15 Authors Shi J , Ma D , Gao S , Long F , Wang X , Pu X , Cannon RD , Han TL , |
|
|
Modulation of gut microbiome in response to the combination of Escherichia coli Nissle 1917 and sugars: a pilot study using host-free system reflecting impact on interpersonal microbiome. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 11 Issue Pages: 1452784 Pub: 2024 Epub: 2024 Oct 22 Authors Heer K , Kaur M , Sidhu D , Dey P , Raychaudhuri S , |
|
|
Human-derived bacterial strains mitigate colitis via modulating gut microbiota and repairing intestinal barrier function in mice. ✅
Go to Publication ✅
BMC microbiology (BMC Microbiol ) Vol: 24 Issue 1 Pages: 96 Pub: 2024 Mar 23 Epub: 2024 Mar 23 Authors Dai J , Jiang M , Wang X , Lang T , Wan L , Wang J , |
|
|
E. coli Nissle 1917 improves gut microbiota composition and serum metabolites to counteract atherosclerosis via the homocitrulline/Caspase 1/NLRP3/GSDMD axis. ✅
Go to Publication ✅
International journal of medical microbiology : IJMM (Int J Med Microbiol ) Vol: 318 Issue Pages: 151642 Pub: 2025 Mar Epub: 2024 Dec 26 Authors Liu H , Ma X , Yang X , Xiao S , Ouyang S , Hu Z , Zhou Z , Jiang Z , |
|
|
E. coli Nissle 1917 improves gut microbiota composition and serum metabolites to counteract atherosclerosis via the homocitrulline/Caspase 1/NLRP3/GSDMD axis. ✅
Go to Publication ✅
International journal of medical microbiology : IJMM (Int J Med Microbiol ) Vol: 318 Issue Pages: 151642 Pub: 2025 Mar Epub: 2024 Dec 26 Authors Liu H , Ma X , Yang X , Xiao S , Ouyang S , Hu Z , Zhou Z , Jiang Z , |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
